Hongyong He

Sun Yat-sen University — China

Medicine · Health Sciences

27h-index2.5kcitations78works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(21), Immune Cell Function and Interaction(19), Gastric Cancer Management and Outcomes(18), Gastrointestinal Tumor Research and Treatment(12), Immune cells in cancer(10)

Publications78 total

Seasonal harvest dictates insecticidal efficacy of Hedychium longipetalum essential oil against stored product pests
Pesticide Biochemistry and Physiology·2025
Disrupting of tissue-resident FOLR2+tumour-associated macrophages-derived interleukin-10 improves anti-PD-1 efficacy in gastric cancer
International Journal of Surgery·2025Open Access
Clinical outcomes and immune contexture in <scp>SMARCA4</scp> ‐deficient gastric cancer patients
The Journal of Pathology·2025
1186P Cadonilimab plus chemotherapy as induction therapy followed by concurrent chemoradiotherapy in locally advanced cervical cancer: A multicenter, single-arm phase II trial
Annals of Oncology·2025Open Access
Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer
British Journal of Cancer·2025
Clinical significance of appendicoliths in elderly patients over eighty years old undergoing emergency appendectomy: A single-center retrospective study
World Journal of Gastrointestinal Surgery·2024· 1 citedOpen Access
Clinical significance of appendicoliths in conservative treatment of acute complicated appendicitis patients with peri-appendiceal abscess: a single-center retrospective study
Annals of Medicine and Surgery·2024Open Access
Clinical significance of peri-appendiceal abscess and phlegmon in acute complicated appendicitis patients undergoing emergency appendectomy
World Journal of Gastrointestinal Surgery·2024Open Access
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer
British Journal of Cancer·2024· 9 citedOpen Access
Clinical significance of appendicoliths in conservative treatment of acute complicated appendicitis patients with peri-appendiceal abscess: A single-center retrospective study
2024Open Access
Clinical significance of peri-appendiceal abscess and phlegmon in acute complicated appendicitis patients undergoing emergency appendectomy: A single-center retrospective study
2024Open Access
Clinical significance of preoperative nutritional status in elderly gastric cancer patients undergoing radical gastrectomy: A single-center retrospective study
World Journal of Gastrointestinal Surgery·2024· 6 citedOpen Access
Clinical outcome and molecular landscape of patients with <i>ARID1A</i>‐loss gastric cancer
Cancer Science·2023· 8 citedOpen Access
Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer
Journal for ImmunoTherapy of Cancer·2023· 21 citedOpen Access
[Clinicopathological and molecular diagnostic features of early-onset gastric cancer: a study based on data from a single-center dedicated gastric cancer database].
PubMed·2023· 1 cited
1393P Characteristics of MET gene and its relationship with TMB/MMR genes in Chinese NSCLC population
Annals of Oncology·2023Open Access
C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer
British Journal of Cancer·2023· 23 citedOpen Access
Surgeons’ mental distress and risks after severe complications following radical gastrectomy in China: a nationwide cross-sectional questionnaire
International Journal of Surgery·2023· 3 citedOpen Access
Complement receptor <scp>C5aR1</scp> blockade reprograms tumor‐associated macrophages and synergizes with <scp>anti‐PD</scp>‐1 therapy in gastric cancer
International Journal of Cancer·2023· 17 citedOpen Access
Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy
Cancer Immunology Immunotherapy·2022· 33 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Chao Lin(33), Jiejie Xu(33), Hao Liu(29), Ruochen Li(29), Heng Zhang(29), Yun Gu(22), Jieti Wang(22), He Li(21), Hanji Fang(18), Kunpeng Lv(17), Yifan Cao(16), Weijuan Zhang(14), Yihong Sun(13), Xudong He(11), Jing Qin(11), Yuchao Fei(10), Xin Liu(8), Zhenbin Shen(8), Kaifeng Jin(7), Yifan Cao(7)